In a research, led by the University of Granada, in which researchers from the Universidad Europea del Atlántico (European University of the Atlantic, UNEATLANTICO), such as Mario Cordero and Maurizio Battino, it has been studied how diets rich in saturated fats and cholesterol influence certain aspects of periodontal diseases.
Apraglutide by Ironwood Pharmaceuticals for Short Bowel Syndrome: Likelihood of Approval
Apraglutide is under clinical development by Ironwood Pharmaceuticals and currently in Phase III for Short Bowel Syndrome.